Surgery: 2,208 Real Stories

2,208 stories match surgery. 1,436 of them mention chemotherapy.

Karina, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Karina's Survivor Story

Patient Info: Karina Bandera, Female, 40s | Stage III

Recovering after treatment for Stage IIIC rectal cancer, including chemotherapy, surgery, sepsis complication, ileostomy, more chemotherapy, and ileostomy reversal; she reported doing well, but explicit NED/remission status is not stated.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Jennifer, who was diagnosed with Stage I Lung CancerLung Cancer

Stage I Lung Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rosato Perea, Female | Stage I

Cancer-free after February 2022 lower-right-lobe lobectomy for Stage I lung cancer, with no chemotherapy, radiation, or clinical trial treatment needed; returned to running and completed endurance events.

Lung Cancer Research Foundation
OutcomeCancer-Free / NED
Sydney, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Sydney Stoner: Stage IIIB to Stage IV colon cancer with liver and lung involvement

Patient Info: Sydney Stoner, Female, Under 40 | Stage IV

Metastatic Site: Liver; lungs

Progressed from Stage IIIB colon cancer to Stage IV disease involving the liver and lungs; treated with surgery/ileostomy/reversal, FOLFOX/FOLFIRI, lung radiation, liver ablation/resection, capecitabine, and ongoing Lonsurf + Avastin.

Fight Colorectal Cancer
OutcomeSetback / Progression
Karen, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Karen's Patient Story

Patient Info: Karen, Female, 40s | Stage IV

Biomarkers: Rare mutation affecting about 3% of lung cancer patients; mutation not named

Metastatic Site: Rib/bone involvement reported through recurrent tumor…

More than 8 years after initial Stage II lung cancer, Karen had a Stage IV recurrence requiring removal of a tumor and 2 ribs; she remained active and hopeful, but ongoing targeted treatment is not specifically stated.

Lung Cancer Research Foundation
OutcomeSetback / Progression
Margaret, who was diagnosed with Stage I Colorectal CancerColorectal Cancer

Stage I Colorectal Cancer: Margaret's Survivor Story

Patient Info: Margaret Mullaney, Female | Stage I

Stage I colorectal cancer treated with surgery, followed by a 5-year surveillance plan and regular testing; chemotherapy and radiation are not described in the available story.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Laura, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Laura Greco: Stage IV Lung Cancer

Patient Info: Laura Greco, Female | Stage IV

Biomarkers: ALK translocation / ALK-driven; MET amplification; EGFR amplification reported in brain tumor

Metastatic Site: Brain

Laura Greco passed away on July 14, 2024 after Stage IIIA ALK-driven lung cancer later metastasized to the brain and required repeated brain-directed treatment and targeted therapy.

Lung Cancer Research Foundation
OutcomeIn Memory
Mila, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Mila's Patient Story

Patient Info: Mila Gardon, Female, 50s | Stage IV

Metastatic Site: Neck lymph nodes; skull; iliac bone

Stage IV lung cancer with spread to neck lymph nodes, skull, and iliac bone responded after cryotherapy and interventional therapy; lung tumors disappeared and tumor marker normalized, but the source does not state full remission or NED.

Modern Cancer Hospital Guangzhou (Lung)
OutcomeResponding Well
Janice, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Janice's Patient Story

Patient Info: Janice Johnson, Female, 40s | Stage IV

Biomarkers: CEA tumor marker elevated after colectomy; biomarker/genomic test results not reported

Metastatic Site: Lungs

Ongoing care for Stage IV colorectal cancer after colectomy, years of chemotherapy, radiation, lung resections for metastatic disease, and pelvic stent exchanges every 3 months.

American Cancer Society
OutcomeCare Ongoing
Linnea, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV ALK Non-Small Cell Lung Cancer: Linnea's Patient Story

Patient Info: Linnea Olson, Female, 40s | Stage IV

Biomarkers: ALK mutation / ALK-rearranged lung cancer

Metastatic Site: Lungs / intrapulmonary disease

Living long term with Stage IV ALK-positive NSCLC; ALK-targeted clinical trials controlled disease for years but were described as disease control rather than cure.

Massachusetts General Hospital
OutcomeLiving With Cancer
Patty, who was diagnosed with Stage I Invasive Lobular CarcinomaBreast Cancer

Stage I Invasive Lobular Carcinoma: Patty's Patient Story

Patient Info: Patty Schone, Female, 60s | Stage I

Biomarkers: Hormone therapy used to lower estrogen; receptor results not otherwise reported

Recovering and continuing daily hormone therapy after double mastectomy, reconstruction, and 16 right-chest radiation treatments for left-breast DCIS and right-breast Stage IB invasive lobular carcinoma with lymph-node involvement.

American Cancer Society
OutcomeCare Ongoing
Robbie, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: Robbie's Patient Story

Patient Info: Robbie, Female | Stage IV

Biomarkers: Estrogen receptor-positive / ER-positive

Metastatic Site: Bone; liver

Living with metastatic breast cancer involving bone and liver after earlier DCIS and Stage II ER-positive breast cancer; ongoing treatment at Mass General focused on stabilization and long-term disease management.

Massachusetts General Hospital
OutcomeLiving With Cancer
Donna, who was diagnosed with Non-Small Cell Lung CancerLung Cancer

EGFR Non-Small Cell Lung Cancer: Donna's Patient Story

Patient Info: Donna Thompson, Female, 40s

Biomarkers: EGFR-positive lung cancer reported during recurrence; initial tumor biomarker status not reported

Recurrent NSCLC after earlier Stage II surgery and limited chemotherapy; later EGFR-targeted therapy caused kidney failure, 2 new spots were radiated in July 2025, and new nodules are under watchful monitoring.

GO2 Foundation
OutcomeSetback / Progression
Kevin, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Kevin's Patient Story

Patient Info: Kevin Jarvis, Male | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

Early male breast cancer treated with mastectomy, sentinel node biopsy, EC chemotherapy, paclitaxel/Taxol, and ongoing daily tamoxifen; latest source text describes good spirits and continued discussion of risk-reducing surgery, but does not explicitly state NED.

Cancer Council Australia
OutcomeCare Ongoing
Lexi, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV EGFR Non-Small Cell Lung Cancer: Lexi's Patient Story

Patient Info: Lexi, Female, Under 40 | Stage IV

Biomarkers: EGFR exon 20 mutation

Metastatic Site: Bone — left leg and hip

Living with Stage IV EGFR exon 20 metastatic NSCLC involving bone, after chemotherapy, targeted therapy, a drug trial, and surgery to remove the primary lung mass; latest disease-control status is not clearly stated.

Lung Cancer Research Foundation
OutcomeLiving With Cancer
Rebecca, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Rebecca's Patient Story

Patient Info: Rebecca Goins, Female, Under 40 | Stage IV

Metastatic Site: Not specified

Recurrent Stage IVB colorectal cancer was found on PET scan after a prior remission; the recurrent tumor was described as inoperable and treatment options were limited to chemotherapy and radiation.

Fight Colorectal Cancer
OutcomeSetback / Progression
Roxanne, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II Invasive Ductal Carcinoma: Roxanne's Survivor Story

Patient Info: Roxanne, Female, Under 40 | Stage II

Biomarkers: Genetic testing reported no hereditary/family-risk finding; tumor biomarker status not reported

Completed chemotherapy, surgery, and radiation for Stage IIB invasive ductal carcinoma; the source title identifies no evidence of disease after treatment, and she described herself as a survivor after finishing treatment on 28 April 2025.

breastcancer.org
OutcomeCancer-Free / NED
Vanessa, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Vanessa's Survivor Story

Patient Info: Vanessa Cuccurullo, Female | Stage I

Clear post-surgery mammogram/check-up after Stage I breast cancer treatment, healed reconstruction and reduction, and return to annual monitoring.

breastcancer.org
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Breast CancerBreast Cancer

Faith And Humility: Stage I Breast Cancer treatment and follow-up story

Patient Info: Anonymized, Female | Stage I

Completed surgery, chemotherapy, and radiotherapy for early breast cancer about 9 months before the story and was living in recovery; no explicit NED/cancer-free status is stated.

breastcancer.org
OutcomeSurvivorship / Surveillance
Michele, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Michele's Survivor Story

Patient Info: Michele Adams, Female

Breast cancer survivor after bilateral mastectomy and reconstruction; the source focuses on recovery, reconstruction, and a career change rather than formal disease status.

breastcancer.org
OutcomeSurvivorship / Surveillance
Karen, who was diagnosed with Stage I Invasive Ductal CarcinomaBreast Cancer

Stage I Invasive Ductal Carcinoma: Karen's Survivor Story

Patient Info: Karen Powell, Female, Under 40 | Stage I

Breast cancer survivor after diagnosis with Stage I invasive ductal carcinoma and bilateral mastectomy/reconstruction planning; source emphasizes early detection, advocacy, and survivorship rather than formal NED wording.

breastcancer.org
OutcomeSurvivorship / Surveillance
Kevin, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Kevin's Survivor Story

Patient Info: Kevin, Male, 50s | Stage III

Biomarkers: Tumor DNA used to create custom blood test for ctDNA monitoring; no actionable biomarker reported

No issues or signs of recurrence 2.5 years after finishing chemotherapy, with clean colonoscopy 1 year after surgery and ongoing liquid-biopsy monitoring.

Colorectal Cancer Alliance
OutcomeCancer-Free / NED
Cher, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Cher's Survivor Story

Patient Info: Cher, Female | Stage III

Biomarkers: Hormone-positive; HER2-negative; Oncotype DX score 0

No evidence of disease after treatment for Stage IIIB breast cancer, with ongoing adjuvant Verzenio, long-term hormone blockers, and planned preventive mastectomy/DIEP flap reconstruction.

breastcancer.org
OutcomeCancer-Free / NED
Gabriel, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Gabriel's Survivor Story

Patient Info: Gabriel Leblanc, Male, Under 40 | Stage III

Stage III colon cancer survivor who avoided an ostomy after total colectomy, completed chemotherapy, returned to full-time work, and is described in the source as moving from Stage III to NED.

Colorectal Cancer Alliance
OutcomeCancer-Free / NED
Helen, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV rectal cancer: no evidence of disease after treatment

Patient Info: Helen D, Female | Stage IV

Metastatic Site: Liver; lymph nodes

Scans showed no evidence of disease after treatment for Stage IV rectal cancer with liver and lymph-node involvement, including chemotherapy, targeted therapy, HAI pump therapy, and liver resection.

Colorectal Cancer Alliance
OutcomeCancer-Free / NED